Literature DB >> 23518631

Combined large cell neuroendocrine carcinoma and adenocarcinoma with epidermal growth factor receptor mutation in a female patient who never smoked.

Yukihiro Yoshida1, Satoshi Ota, Tomohiro Murakawa, Daiya Takai, Jun Nakajima.   

Abstract

A female patient in her sixties, who had never smoked, was found to have a 5-mm nodule in a computed tomography (CT) scan. The follow-up CT scan after 19 months showed that the nodule had grown to 26 mm. We performed a left upper lobectomy. Pathological examination revealed a combined large cell neuroendocrine carcinoma (LCNEC) and adenocarcinoma with components of large cell carcinoma and bronchioloalveolar carcinoma (BAC). Tumor cells were separately collected from components of both the LCNEC and adenocarcinoma, and a mutational analysis of the epidermal growth factor receptor (EGFR) gene demonstrated that both components had the same L861Q mutation at exon 21. We assume that the LCNEC originated from the adenocarcinoma based on the fact that the patient was a non-smoking female, the tumor was located in the periphery, the tumor had a BAC component, and the same EGFR mutation was found in both the LCNEC and adenocarcinoma components.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518631     DOI: 10.5761/atcs.cr.12.02217

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  5 in total

Review 1.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

Review 2.  Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.

Authors:  Yi Shao; Dian-Sheng Zhong
Journal:  Int J Clin Oncol       Date:  2017-11-07       Impact factor: 3.402

Review 3.  Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Akira Iyoda; Takashi Makino; Satoshi Koezuka; Hajime Otsuka; Yoshinobu Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-10

Review 4.  Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.

Authors:  Miriam Grazia Ferrara; Alessio Stefani; Michele Simbolo; Sara Pilotto; Maurizio Martini; Filippo Lococo; Emanuele Vita; Marco Chiappetta; Alessandra Cancellieri; Ettore D'Argento; Rocco Trisolini; Guido Rindi; Aldo Scarpa; Stefano Margaritora; Michele Milella; Giampaolo Tortora; Emilio Bria
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

5.  Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report.

Authors:  Rika Moriya; Satoshi Hokari; Satoshi Shibata; Takeshi Koizumi; Takafumi Tetsuka; Kazuhiko Ito; Hideki Hashidate; Hiroki Tsukada
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.